Myeloma Masters: The Ultimate Myeloma Patient Care Quiz Show
Jointly provided by
Support for this activity has been provided through educational grants from Karyopharm Therapeutics, Inc. and Sanofi Genzyme.
Release date: 4/27/2022
Expiration date: 5/27/2023
Estimated time to complete: 0.5 hour
Multiple myeloma management has advanced significantly in recent years, providing new hope for myeloma patients but creating new challenges for health care providers. Using an engaging and entertaining game show format (think Who Wants to Be a Millionaire), this activity tests players’ knowledge of current and emerging myeloma patient care best practices. Along the way—using a range of multimedia prompts and hints—the game presents information on several fast-evolving areas of myeloma care, such as optimal use of staging tests, new therapies for both newly diagnosed and relapsed/refractory patients, and adverse event management. As players correctly answer questions, they accumulate points that will—hopefully!—earn them the title of Myeloma Master.
Amy E. Pierre, RN, MSN, ANP-BC
New York, New York
Memorial Sloan Kettering Cancer Center
Montvale, New Jersey
This activity has been designed to meet the educational needs of oncology nurses, advanced oncology certified nurse practitioners, and other health care providers involved in the care of patients with multiple myeloma.
Upon completion of this activity, participants should be better able to:
- Interpret cytogenetic, molecular, and other standard staging tests used to define risk and prognosis for patients with myeloma precursor conditions and multiple myeloma
- Distinguish between the indicated uses and mechanisms of action of current and emerging treatment regimens
- Evaluate emerging data regarding the approach to minimal residual disease testing
- Describe the toxicity profile for newer agents used for the treatment of patients with multiple myeloma and ways to minimize the impact of treatment-related side effects
- Create patient-centered management plans with patients and other members of the care team to provide education on disease prognosis and treatment
Accreditation and Credit Designation
Purdue University School of Nursing is accredited by the American Nurses Credentialing Center (ANCC) to provide nursing continuing professional development (NCPD) in collaboration with the University’s College of Pharmacy.
This activity is approved for 0.5 ANCC contact hour.
According to the disclosure policy of Purdue University School of Nursing, all faculty, planning committee members, and other individuals who are in a position to control content are required to disclose any relationship with ineligible companies. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosures are as follows and have been mitigated:
Amy E. Pierre, RN, MSN, ANP-BC, has disclosed no relationships with ineligible companies.
Purdue University School of Nursing
Faculty and staff involved in the development and review of this activity have disclosed no relationships with ineligible companies.
Multiple Myeloma Research Foundation
Mary DeRome, Senior Director of Medical Communications and Education, has disclosed no relationships with ineligible companies.
The RedMedEd planners have disclosed no relationships with ineligible companies.
Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Purdue University School of Nursing, RedMedEd, the Multiple Myeloma Research Foundation, Karyopharm Therapeutics, and Sanofi Genzyme do not recommend the use of any agent outside the labeled indications.
The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Purdue University School of Nursing, RedMedEd, the Multiple Myeloma Research Foundation, Karyopharm Therapeutics, or Sanofi Genzyme. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Method of Participation
There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive CE credit for participation, participants must complete one round of the game (achieving the required score) and the activity evaluation. Certificates can be printed immediately.
For questions regarding CE credit, contact Purdue University School of Nursing at Pharmacy-CECR@purdue.edu.
For technical questions related to this activity, please contact RedMedEd at 610.251.6841 or firstname.lastname@example.org.
- Apple iPad, iPad Mini (iPadOS 14 or higher), iPhones (iOS 14 or higher), or Android device (OS 11 or higher) with an Internet connection
- Internet browsers: Chrome, Firefox, Safari
- A computer with an Internet connection
- Internet browsers (PC): Chrome, Firefox, Microsoft Edge
- Internet browsers (Mac): Chrome, Firefox, Safari
© 2022. This CE-certified program is held as copyrighted by Purdue University School of Nursing, the Multiple Myeloma Research Foundation, and RedMedEd. Through this notice, Purdue University School of Nursing, Multiple Myeloma Research Foundation, and RedMedEd grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owners.